Approved by the FDA in the 1970s, Tamoxifen revolutionized the treatment of ER+ breast cancer by providing a targeted approach that interferes with cancers hormonal fuel source without completely suppressing estrogen throughout the body
Results were similar in various sensitivity analyses, including analyses with additional active comparator (i.e., all other non-insulin agents except SGLT2i), as-treated analyses, and competing risk analyses
Common Side Effects Experienced by some users Hypoglycemia (low blood sugar) This is the most important side effect to understand
however, it is likely that these plans will broaden coverage to include patients 12 years and older when they next update their policies
A Quick Recap Vitamin D and B12 deficiency is more common than many realize, and its symptoms often go unnoticed until they begin affecting daily life
We offer a comprehensive approach utilizing functional naturopathic medicine including: Dr